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Background: Metabolic disorders, including type II diabetes 
and obesity, present major health risks in industrialized 
countries. AMP-activated protein kinase (AMPK) has be-
come the focus of a great deal of attention as a novel ther-
apeutic target for the treatment of metabolic syndromes. In 
this study, we evaluated whether dietary aloe could reduce 
obesity-induced inflammation and adipogenesis. Methods: 
Male C57BL/6 obese mice fed a high-fat diet for 54 days re-
ceived a supplement of aloe formula (PAG, ALS, Aloe QDM, 
and Aloe QDM complex) or pioglitazone (PGZ) and were 
compared with unsupplemented controls (high-fat diet; HFD) 
or mice fed a regular diet (RD). RT-PCR and western blot 
analysis were used to quantify the expression of obesity-in-
duced inflammation. Results: Aloe QDM complex down-
regulated fat size through suppressed expression of scav-
enger receptors on adipose tissue macrophages (ATMs) 
compared with HFD. Both white adipose tissue (WATs) and 
muscle exhibited increased AMPK activation through aloe 
supplementation, and in particular, the Aloe QDM complex. 
Obesity-induced inflammatory cytokines (IL-1β and -6) and 
HIF1α  mRNA and protein were decreased markedly, as was 
macrophage infiltration by the Aloe QDM complex. Further, 
the Aloe QDM complex decreased the translocation of 
NF-κB p65 from the cytosol in the WAT. Conclusion: 
Dietary aloe formula reduced obesity-induced inflammatory 
responses by activation of AMPK in muscle and suppression 
of proinflammatory cytokines in the WAT. Additionally, the 
expression of scavenger receptors in the ATM and activation 
of AMPK in WAT led to reduction in the percent of body fat. 
Thus, we suggest that the effect of the Aloe QDM complex in 
the WAT and muscle are related to activation of AMPK and 
its use as a nutritional intervention against T2D and obe-
sity-related inflammation.
[Immune Network 2011;11(2):107-113]
INTRODUCTION
Adipose tissue acts as a central regulator of energy metabo-
lism  and  vascular  homeostasis by  secreting a  diverse  range 
of  adipokines,  such  as  adiponectin,  leptin,  and  proin-
flammatory mediators (1). Excessive expansion of white adi-
pose tissue (WAT), the hallmark of obesity, is a potent risk 
factor  for  type  II  diabebetes  (T2D)  and  cardiovascular  dis-
eases  (2).  Inflammation  in  WAT,  characterized  by  macro-
phage infiltration and elevated production of adipokines such 
a s  l e p t i n  a n d  p r o i n f l a m m a t o r y  c y t o k i n e s  h a s  p l a y e d  a  k e y  
role in linking obesity with insulin resistance and metabolic 
dysfunction  (3,4).
    AMP-activated protein kinase (AMPK) is a phylogenetically 
conserved intracellular energy sensor that plays a central role 
in the regulation of glucose and lipid metabolism. AMP-acti-
vated protein kinase is a heterotrimeric complex composed 
of a catalytic subunit and two regulatory subunits, and is acti-
vated when cellular energy is depleted (5). Recently, it has 
been  found  that  AMPK  plays  an  important  role  in  in-
flammation (6) and accelerates ATP-generating catabolic path-
ways, including glucose and fatty acid oxidation (7,8). In vi-Dietary Aloe Reduces Adipogenesis and Suppresses Obesity-related Inflammation
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tro  and  in  vivo  studies  have  demonstrated  that  the  AMPK 
agonist,  5-aminoimidazole-4-carboxy-amide-1-D-ribofuranoside 
(AICAR), enhances insulin-mediated glucose transport and in-
sulin  action  in  muscle  and  liver  of  insulin-resistant  rats  fed 
a  high  fat  diet  (9,10).
    Aloe species have been used for centuries for their anti-in-
flammatory (11), immunostimulant, antiseptic (12), burn heal-
ing (13), and antitumor activities (14). Fifty years ago, Mertz 
and coworkers proposed that chromium (Cr) was an essential 
trace element (15,16) and that it was required for normal car-
bohydrate and lipid metabolism (17-19). However, it remains 
unclear as to whether Aloe mediates the activation of AMPK, 
especially  in  muscles  and  WAT.
  In the present study, we examine whether the Aloe QDM 
complex does indeed down-regulate inflammatory responses 
and  adipogenesis  and  further,  how  it  exhibits  anti-inflam-
matory responses in WAT. We demonstrated that Aloe QDM 
complex reduced the expression of scavenger receptors and 
the expression of  proinflammatory  cytokines in obese  mice 
in an AMPK-dependent manner. These results suggested that 
the Aloe QDM complex would exhibit advantageous effects 
in  cases  of  obesity-related  metabolic  disorders  through  an 
AMPK  stimulatory  mechanism.
MATERIALS AND METHODS
Chemicals and reagents
Processed Aloe vera gel (PAG) (20), Aloesin (ALS), Aloe QDM, 
and Aloe QDM complex (21) were provided by Univera, Inc. 
(Seoul,  Republic  of  Korea).  Pioglitazone  (Actos
Ⓡ) was pur-
chased from Eli Lilly (Toronto, Canada); chromium (Cr) was 
purchased from Lallemand Inc. (Montreal, Canada); and leu-
peptin, aprotinin, and phenylmethylsulfonyl fluoride (PMSF) 
were  purchased  from  Sigma  Chemical  Co.  (St.  Louis,  MO, 
USA). Antibodies of Hypoxia induced factor 1 alpha (HIF-1α) 
and  NF-κB  p65  were  purchased  from  Novus  Biologicals 
(Littleton,  CO,  USA)  and  Santa  Cruz  Biotechnology  Inc., 
( S a n t a  C r u z ,  C A ,  U S A ) ,  r e s p e ctively.  Anti-mouse  AMP-acti-
vated protein kinase alpha (AMPKα) and phospho-AMPKα 
(Thr172)  were  purchased  from  Cell  Signaling  Technology 
(MA, USA), and all other chemicals and reagents used in this 
study  were  reagent  grade.
Animals and diets
Male C57BL/6NCrjBgi mice were purchased from the Charles 
River  Laboratory  of  Animal  Science  (Orient  Co.,  Seoul, 
Republic of Korea) at four weeks old and fed a normal diet 
for one week. Animals were housed in individual cages with 
free access to water and food in a temperature-controlled ani-
mal  facility  under  a  12  h  light-dark  cycle  at  22±2
oC  and 
55±5% humidity. Mice were fed either a high-fat diet (HFD) 
(Open  Source  diets  #D12492;  Research  Diets  Inc.,  New 
Brunswick, NJ) to induce obesity, or a regular diet (RD; Open 
Source diets #D12450B; Research Diets Inc.). The nutritional 
contents of the HFD were similar to those on the regular diet 
except for low carbohydrate content and a high level of fat.
    At 26 weeks of age, mice exhibiting blood glucose levels 
＞160 mg/dl were selected as non-insulin-dependent diabetes 
mellitus (NIDDM) animals and were divided into five groups 
of 20 animals per group. One group was administrated PBS 
only  and  served  as  diabetic  controls;  four  groups  received 
daily  100  mg/kg  of  PAG,  2  mg/kg  of  Aloesin  (ALS),  100 
mg/kg  of  PAG  containing  2%  ALS  (Aloe  QDM),  and  Aloe 
QDM plus 500 mg/kg of Cr-enriched yeast containing 0.2% 
Cr (Aloe QDM complex) respectively, and the fifth group was 
administered pioglitazone (PGZ, 2.5 mg/kg), an anti-diabetic 
drug currently in clinical use. Mice were weighed and blood 
samples  were  collected  weekly  by  tail  bleeding  into  hep-
arin-coated  tubes  after  4  h  fasts.
    At the end of the experimental period, mice were sacrificed 
and  WAT  were  immediately  removed  from  periepididymal 
and perirenal fat for morphological examination. Mice were 
treated  in  accordance  with  the  guidelines  issued  by  Sahm-
yook University for the care and use of laboratory animals.
Histological analysis
Adipose tissue was isolated from mice, fixed in 10% formalin, 
and  embedded  in  paraffin.  Four-micrometer  thin  sections 
were obtained, mounted on two glass-slides, and stained with 
hematoxylin-eosin.  Sections  were  viewed  with  an  Olympus 
microscope (Olympus, Tokyo, Japan) at 400X magnification.
Isolation of total RNA and reverse transcription poly-
merase chain reaction (RT-PCR)
Twenty mice were selected and used for this analysis. WAT 
and muscles were immediately frozen in liquid nitrogen and 
stored  at  −70
oC  for  the  determination  of  gene  transcripts. 
Total RNA was extracted from tissues using the RNeasy Mini 
kit (QIAGEN, Valencia, USA) in an RNase-free environment. 
RNA was then quantified by reading the absorbance at 260 
nm. The reverse transcription of 1μg RNA was carried out 
using M-MLV reverse transcriptase (Promega, USA), an oligo Dietary Aloe Reduces Adipogenesis and Suppresses Obesity-related Inflammation
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Figure 1. Effects of aloe formulas on cell counts in the epididymal
fat pad. The fat cell count in 7.35 mm
2 from hematoxylin and 
eosin-stained paraffin sections of the fat pad.
(dT)  16  primer,  dNTP  (0.5μM),  and  1  U  RNase  inhibitor. 
After  incubation  at  65
oC  for  5  min  and  37
oC  for  60  min, 
M-MLV  reverse  transcriptase  was  inactivated  by  heating  at 
70
oC for 15 min. The polymerase chain reaction (PCR) was 
performed in 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5 mM 
MgCl2, and 2.5 mM dNTPs with 5 units of Taq DNA polymer-
ase, and 10 pM of each primer set for CD36, scavenger re-
ceptor A (SR-A), interleukin (IL)-1β, and interleukin (IL)-6. 
The cDNA was amplified by 35 cycles of denaturing at 94
oC 
for 45 s, annealing at 62
oC for 45 s, and extension at 72
oC 
for 1 min. Final extension was performed at 72
oC for 5 min. 
The PCR products were then electrophoresed on 1.5% agar-
ose gels and stained with ethidium bromide. The primers se-
lected  were  5’ A G T  A G G  C G T  G G G  T C T  G A A  G G  3 ’ 
(forward) and 5’ CTT GCT TGC CCA GTC ACA GG 3’ (re-
verse) for CD36, 5’ GGA GAC AGA GGG CTT ACT GG 3’ 
(forward)  and  5’  GTT  GAT  CCG  CCT  ACA  CTC  CC  3’ 
(reverse)  for  SR-A,  5’ C A G  G A T  G A G  G A C  A T G  A C A  C C’ 
(forward)  and  5’ C T C  T G C  A G A  C T C  A A A  C T C  C A C 3 ’ 
(reverse) for IL-1β, 5’ GTA CTC CAG AAG ACC AGA GG 
3’ (forward) and 5’  TGC  TGG TGA CAA  CCA  CGG CC 3’ 
(reverse) for IL-6, and 5’ CAA CTT TGG CAT TGT GGA AGG 
3’ (forward) and 5’ ATG GAA ATT GTG AGG GAG ATG C 
3’  (reverse)  for  GAPDH,  which  was  used  as  an  internal 
control.
Preparation of nuclear extracts
After homogenized tissues were collected and washed twice 
with cold PBS, they were resuspended in ice lysis buffer (20 
mM Trizma base, 50 mM NaCl, 250 mM sucrose, 50 mM NaF, 
5 mM Na4P2O7ㆍ10H2O, 1% Triton-X100, 5μg/ml leupeptin, 
1  mM  phenylmethylsulfonyl  fluoride  (PMSF),  and  5μg/ml 
aprotinin).  After  15  min  incubation  on  ice,  the  cells  were 
lysed by the addition of 0.1% NP-40 and vigorous vortexing 
for  1  min.  The  nuclei  were  pelleted  by  centrifugation  at 
12,000×g for 1 min at 4
oC and resuspended in high salt buf-
fer (20 mM HEPES, pH 7.9, 25% glycerol, 400 mM KCl, 1.5 
mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 1 mM NaF, 1 mM 
sodium orthovanadate). The supernatant fluid was stored in 
aliquots  at  −70
oC.
Western blot analysis
Frozen epididymal adipose tissue and muscles were homo-
genized in 3 volumes of ice lysis buffer (20 mM Trizma base, 
50 mM NaCl, 250 mM sucrose, 50 mM NaF, 5 mM Na4P2O7ㆍ
10H2O,  1%  Triton-X100,  5μg/ml  leupeptin,  1  mM  phenyl-
methylsulfonyl  fluoride  (PMSF),  and  5μg/ml  aprotinin). 
Twenty micrograms of protein from cell lysates were applied 
to  8∼12% SDS-polyacrylamide gels and then transferred to 
nitrocellulose  membranes.  The  membranes  were  blocked 
with 5% skim milk in TBST solution for 1 hr. They were then 
incubated with anti-HIF1α, anti-AMPK, anti-p-AMPK, and an-
ti-p65 monoclonal antibodies for 2 hrs and washed 3 times 
with  TBST.  After  incubation  with  alkaline  phosphatase-la-
beled secondary antibody for 2 hrs, the bands were visualized 
using a Western Blot Kit with an alkaline phosphatase sub-
strate  (Vector,  Burlingame,  USA).
Statistical analysis
A l l  d a t a  h a v e  b e e n  p r e s e n t e d  a s  m e a n ± S E M  v a l u e s .  
Significant differences (p＜0.05) between groups were eval-
uated  using  a  one-way  analysis  of  variance  with  SPSS 
(Chicago,  IL,  USA)  for  Windows  and  Duncan’s  Multiple 
Range  Test  where  appropriate.
RESULTS
Reduction in adipocyte size via the suppression of 
scavenger receptors on macrophages in the WAT of 
obese mice
CD36 and SR-A are scavenger receptors for oxidized low-den-
sity  lipoprotein  (oxLDL)  and  cellular  transporters  of  long- 
c h a i n  f a t t y  a c i d  ( 2 2 ) .  I n  t h e  p r e s e n t  s t u d y ,  w e  e x a m i n e d  
changes in the level of expression of scavenger receptors and 
their affect on the amount of adipose tissues in obese mice. 
We  obtained  WAT,  stained  with  H&E,  then  counted  the 
adipocytes. Numerous adipocytes completely disappeared af-Dietary Aloe Reduces Adipogenesis and Suppresses Obesity-related Inflammation
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Figure 2. Effects of aloe formulas on obesity-related inflammatory
receptors. WAT were isolated from mice. mRNA expression of 
scavenger receptors in the WAT were measured by RT-PCR. This was
repeated in triplicate and similar results were obtained in all three.
Figure 3. Effects of aloe formulas on AMPK phosphorylation. WAT 
and muscles were isolated from mice. Protein expression in the (A)
WAT and (B) muscles were measured by western blot. This was 
repeated in triplicate and similar results were obtained in all three.
Figure 5. Effects of aloe formulas on NF-κB activation. WAT were
isolated from mice. Protein expression of NF-κB p65 were measured
by western blot. This was repeated in triplicate and similar results 
were obtained in all three.
Figure 4. Effects of aloe formulas on proinflammatory cytokines. WAT
were isolated from mice. (A) Protein expression of HIF1α were 
measured by western blot. (B) mRNA expression of IL-1β and IL-6 
were measured by RT-PCR. This was repeated in triplicate and similar
results were obtained in all three.
ter aloe formula supplementation, especially after Aloe QDM 
complex  supplementation  (Fig.  1).  In  agreement  with  this, 
levels of scavenger receptors such as SR-A and CD36 in the 
WAT were significantly lower in obese mice suppplemented 
with  dietary  aloe  formula  than  in  the  HFD  group  (Fig.  2). 
These  findings  indicated  that  dietary  aloe  formula  supple-
mentation suppressed fat size through inhibition of scavenger 
receptors  in  ATM.
Aloe QDM complex enhances AMPK phosphorylation 
in the both WAT and muscles
We demonstrated that aloe formulas increased AMPKα phos-
phorylation in both WAT and muscles. Since the AMPK cas-
cade has been shown to activate insulin signaling (10), we 
hypothesized that AMPK might be involved in the effect of 
lipolysis on WAT. The Aloe QDM complex enhanced phos-
phorylation of AMPK in tissues (Fig. 3), a finding indicating 
that dietary aloe formula reduced fat levels through mitochon-
drial  biogenesis.
Reduction of inflammatory responses via suppression 
of NF-κB in WAT
To examine whether the dietary aloe formula modulated obe-
sity-induced  inflammation,  we  measured  a  proinflammatory 
cytokine gene and its transcription factor, NF-κB p65, and 
protein expression in WAT by RT-PCR and western blot. As 
shown in Figs. 4A and B, HIF1α protein and proinflamma-
tory  cytokines,  IL-1β and  IL-6  mRNA  were  lower  in  the 
obese mice supplemented with aloe formula than in the HFD 
group.  The  transcription  factor,  NF-κB  p65  was  also  in-
hibited  by  aloe  formulas,  and  in  particular,  the  Aloe  QDM 
complex (Fig. 5). These findings indicated that aloe formulas, 
and especially the Aloe QDM complex reduce WAT inflam-
matory  responses  through  inactivation  of  NF-κB  p65.
DISCUSSION
We previously demonstrated that the Aloe QDM complex re-
duced fat via a suppression of the expression of scavenger Dietary Aloe Reduces Adipogenesis and Suppresses Obesity-related Inflammation
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receptors and obesity-related inflammatory cytokines through 
activation of AMPK and inhibition of translocation of NF-κB 
p65  proteins  in  WAT  and  muscles.
    Herbal  prescriptions  have  been  recognized  as  potentially 
valid  by  the  scientific  medical  establishment,  and  their  use 
has been increasing. Since traditional herbal prescriptions are 
generally  prepared  from  a  combination  of  crude  drugs,  on 
the basis of oriental prescriptions, they may exert combined 
effects that differ from the sum of the effects of the individual 
constituents  (22).
    Dietary aloe formula has been demonstrated to affect in-
flammation by virtue of an immunosuppression. Recent stud-
ies have suggested that inflamed adipocytes in the obese trig-
ger  the  development  of  obesity-related  metabolic  disorders 
such as insulin resistance and T2D, indicating that the reduc-
tion of tissue inflammation may be beneficial in obesity-re-
lated metabolic diseases. Our previous in vivo study demon-
strated a potential effect of PAG, an aloe formula, on hypo-
glycemia and hypolipidemia (20,21). In particular, our results 
demonstrated that the administration of aloe formulas includ-
ing PAG, ALS, Aloe QDM, and Aloe QDM complexes to these 
mice prevented the development of T2D-related symptoms. 
However, the prevention or a therapeutic effect on obesity-in-
duced metabolic disorders has never been fully established.
    The most important finding in this study was that aloe for-
mulas reduced body fat via activation of AMPK in the both 
WAT and muscle (Figs. 1 and 3). Other parameters such as 
proinflammatory  activi t y  a l s o  s u p p o r t e d  a  r e d u c t i o n  o f  i n -
flammation via the inhibition of translocation of NF-κB p65 
by aloe formula supplementation in obese mice (Figs. 4B and 
C). These results reveal that the aloe formulas increased mi-
tochondrial biogenesis in the both WAT and muscles by acti-
vation  of  AMPK  and  further,  reduced  body  fat  by  down-
regulating the expression of scavenger receptors in the WAT. 
This  implies  that  aloe  formulas,  especially  the  Aloe  QDM 
complex  oppose  the  development  of  an  inflammation  state 
and  adipogenesis.
    Scavenger  receptors,  specifically  SR-A  and  CD36  have 
played crucial roles in the pathogenesis of atherosclerotic le-
sions by identifying and facilitating the uptake of oxLDL (23). 
In phagocytes, CD36 primarily functions as a scavenger re-
ceptor,  recognizing  specific  self  and  nonself  molecular  pat-
terns and triggering internalization and inflammatory signaling 
pathways  to  eliminate  pathogens  and  altered  self  compo-
nents, such as apoptotic cells (24,25). CD36 cooperates with 
t o l l - l i k e  r e c e p t o r  ( T L R ) - 4  a n d  - 6  t o  m e d i a t e  t h e  s t e r i l e  i n -
flammatory response to altered self components oxLDL (26) 
and also acts as a coreceptor with TLR2 and -6 in the recog-
nition  of  microbial  diacylglycerides  (27,28).  Interestingly, 
TLR4  recently  has  been  suggested  to  mediate  lipid-induced 
inflammation (29,30). Despite the important role of adipose 
tissue-resident macrophages in the pathogenesis of insulin re-
sistance, to our knowledge this is first study measuring the 
expression of scavenger receptor genes in diet-induced obe-
sity (DIO) mice supplemented  with  aloe. Our data demon-
strated  that  the  aloe  formulas  decreased  protein  expression 
of scavenger receptors in WAT of obese mice (Fig. 2), and 
indicated that the Aloe QDM complex suppressed the scav-
enger  receptor  expression  in WAT leading to reduced total 
fat  mass  in  obese  mice.
    Obesity  is  associated  with  insulin  resistance  and  T2D. 
Massive development of the adipose tissue leads to the for-
m a t i o n  o f  h y p o x i c  a r e a s .  A s  a d i p o s e  t i s s u e  e x p a n d s ,  s o m e  
adipocytes become too distant from the vasculature to be cor-
rectly oxygenated (31). In humans, the existence of hypoxia 
in the adipose tissue of obese patients is supported by the 
observation that although obese patients have more adipose 
tissue than lean patients, the cardiac output and blood flow 
directed  to  adipose  tissue  do  not  increase  (32).  Moreover, 
HIF-1 and HIF-1 target genes are over-expressed in the adi-
pose tissue of obese individuals and subsequently, decrease 
after  weight  loss  (33).  Finally,  obesity  has  been  associated 
with hypertrophic adipocytes in which size prohibits a correct 
diffusion of oxygen within the tissue. Our data demonstrated 
that the aloe formulas decreased protein expression of HIF1α 
i n  W A T  o f  o b e s e  m i c e  ( F i g .  4 A ) ,  a n d  i n d i c a t e d  t h a t  A l o e  
QDM  complex  suppressed  the  HIF1α expression  in  WAT 
leading  to  reduced  obesity-related  inflammation  in  obese 
mice.
    In nearly all data, the Aloe QDM complex has been dem-
onstrated  to  significantly  improve  inflammation  and  adipo-
genesis in WAT and muscles, suggesting that Cr supplementa-
tion with an aloe formula may regulate inflammation homeo-
stasis  in  DIO  mice.
    In  conclusion,  aloe  formulas  suppressed  obesity-induced 
inflammatory  responses  by  reducing  levels  of  the  HIF1α, 
proinflammatory cytokines, and related transcription factor in 
WAT and also improved lipid dysfunction via the suppression 
of the expression of scavenger receptors leading to reduced 
fat levels. The beneficial effects of aloe formula supplementa-
tion with respect to obesity-induced inflammation have been 
associated with its action on AMPK. In the current study, we Dietary Aloe Reduces Adipogenesis and Suppresses Obesity-related Inflammation
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demonstrated that the Aloe QDM complex was a useful diet-
ary phytochemical for improving not only obesity-induced in-
flammation  but  also  obesity-related  metabolic  disorders.
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